Early triple antiviral therapy for COVID-19.

Lee, Nelson; Ison, Michael; Dunning, Jake

Lee, Nelson; Ison, Michael; Dunning, Jake.

Lee N; Department of Medicine, University of Alberta, Edmonton, AB T6G 2G3, Canada. Electronic address: laishunn@ualberta.ca.
Ison M; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Comprehensive Transplant Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Dunning J; National Heart and Lung Institute, Imperial College London, London, UK.

Lancet ; 396(10261): 1487-1488, 2020 11 07.

Article in English | MEDLINE | ID: covidwho-953992

Subject(s)

Antiviral Agents; Coronavirus Infections; Pandemics; Pneumonia, Viral; Antiviral Agents/therapeutic use; Betacoronavirus; COVID-19; Coronavirus Infections/drug therapy; Coronavirus Infections/epidemiology; Humans; Interferon beta-1b/therapeutic use; Lopinavir; Ribavirin/therapeutic use; Ritonavir/therapeutic use; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Coronavirus Infections / Pandemics Type of study: Observational study Limits: Humans Language: English Journal: Lancet Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google